The Thalassaemia International Federation (TIF) is beyond excited to announce the launch of the first-ever ‘Guidelines for the Management of α-Thalassaemia’.
This groundbreaking resource is specifically tailored to healthcare professionals, researchers, and anyone involved or interested in the care of individuals with α-thalassaemia. As a complex genetic and hereditary haemoglobinopathy, α-thalassaemia often goes undiagnosed, causing people to seek help only at advanced stages of complications.
These TIF guidelines represent a significant milestone in thalassaemia history. They provide invaluable insights into the diagnosis and the management of Non-Transfusion Dependent α-Thalassaemia.
By making this resource available, we are taking a giant leap forward in improving patient care, while also enhancing our understanding of α-thalassaemia’s overall impact on patient quality of life and social integration.